PubMed 14 Smith GL, Bunker GB, Dinneen MD: Fournier’s gangrene

PubMed 14. Smith GL, Bunker GB, Dinneen MD: Fournier’s gangrene. BJU 1998, 81:347–355.PubMedCrossRef 15. Fournier JA: Citarinostat mouse gangrene foudroyante de la verge. Medecin Practique 1883, 4:589–597. 16. Unalp HR, Kamer E, Derici H, Atahan K, Balci U, Demirdoven C, Nazli O, Onal MA: Fournier’s gangrene: Evaluation of 68 patients and analysis of prognostic variables. J Postgrad Med 2008, 54:102–105.PubMedCrossRef 17. Tuncel A, Aydin O, Tekdogan U: Fournier’s Gangrene: Three years of experience with 20 patients and validity of the Fournier’s gangrene severity index score. Eur Urol 2006, 50:838–843.PubMedCrossRef 18. Czymek R, Frank P, Limmer S, Schmidt A, Jungbluth T, Roblick U, Bürk C,

Bruch HP, Kujath P: Fournier’s gangrene: is the Emricasan cell line female gender a risk factor? Langenbecks Arch Surg 2010, 395:173–180.PubMedCrossRef 19. Malik AM, Sheikh S, Pathan R, Khan A, Sheikh U: The spectrum of presentation and management of Fournier’s gangrene-An Experience LY2090314 chemical structure of 73 Cases. J Pak Med Assoc 2010, 60:617–619.PubMed 20. Sallami S, Maalla R, Gammoudi A, Ben Jdidia G, Tarhouni L, Horchani A: Fournier’s Gangrene: What are the prognostic factors? Our experience with 40 patients. La Tunisie Medicale 2012, 90:708–714.PubMed 21. Yilmazlar T, Ozturk E, Ozguc H: Fournier’s Gangrene: An analysis of 80 patients and a novel scoring system. Tech Coloproctol 2010, 14:217–223.PubMedCrossRef

22. Ruiz-Tovar J, Córdoba L, Devesa JM: Prognostic Factors in Fournier Gangrene. Asian J Surg 2012, 35:37–41.PubMedCrossRef 23. García A, Martín J, Vaquero A, Sánchez T, de Tomás J, Lago J, Turégano F: Fournier’s gangrene: analysis of prognostic variables in 34 patients. European Journal of Trauma and Emergency Surgery 2011, 37:141–145.CrossRef 24. Jarboui S, Jarraya H, Daldoul S, Zaouche A: Étude clinique et thérapeutique et analyse pronostique des gangrènes du périnée. Presse Med 2008, 37:760–766.PubMedCrossRef

25. Dahm P, Roland FH, Vaslef SN, Moon RE, Price DT, Georgiade GS, Vieweg J: Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology 2000, Dolichyl-phosphate-mannose-protein mannosyltransferase 56:31–35.PubMedCrossRef 26. Nisbet AA, Thompson IM: Impact of diabetes mellitus on the presentation and outcomes of Fournier’s gangrene. Urology 2002, 60:775–779.PubMedCrossRef 27. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI: Outcome prediction in patients with Fournier’s gangrene. J Urol 1995, 154:89–92.PubMedCrossRef 28. Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C: Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int 2012, 89:173–179.PubMedCrossRef 29. Ersoz F, Sari S, Arikan S, Altiok M, Bektas H, Adas G, Poyraz B, Ozcan O: Factors affecting mortality in Fournier’s gangrene: experience with fifty-two patients. Singapore Med J 2012, 53:537–540.PubMed 30.

Comments are closed.